TNBC, a remarkably aggressive form of breast cancer, is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [1]. This evidence concerns the gene ERBB2 and breast carcinoma.